Literature DB >> 26585614

Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?

Pranav Kansara1, Sandra Weiss1, William S Weintraub1, Matthew C Hann2, James Tcheng2, S Tanveer Rab3, Lloyd W Klein4.   

Abstract

Entities:  

Keywords:  CABG; PCI; cost effectiveness; quality of life; stent(s)

Mesh：

Year:  2015        PMID： 26585614      PMCID： PMC5646675          DOI： 10.1016/j.jcin.2015.07.020

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN： 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  27 in total

1.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  J Am Coll Cardiol       Date:  2011-11-07       Impact factor: 24.094

2.  External validity of randomised controlled trials: "to whom do the results of this trial apply?".

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

3.  Scientific evidence underlying the ACC/AHA clinical practice guidelines.

Authors:  Pierluigi Tricoci; Joseph M Allen; Judith M Kramer; Robert M Califf; Sidney C Smith
Journal:  JAMA       Date:  2009-02-25       Impact factor: 56.272

4.  Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.

Authors:  Friedrich W Mohr; Marie-Claude Morice; A Pieter Kappetein; Ted E Feldman; Elisabeth Ståhle; Antonio Colombo; Michael J Mack; David R Holmes; Marie-angèle Morel; Nic Van Dyck; Vicki M Houle; Keith D Dawkins; Patrick W Serruys
Journal:  Lancet       Date:  2013-02-23       Impact factor: 79.321

5.  ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.

Authors:  Manesh R Patel; Gregory J Dehmer; John W Hirshfeld; Peter K Smith; John A Spertus
Journal:  J Am Coll Cardiol       Date:  2012-01-30       Impact factor: 24.094

6.  Cognitive function 5 years after randomization to coronary angioplasty or coronary artery bypass graft surgery.

Authors:  M A Hlatky; C Bacon; D Boothroyd; E Mahanna; J G Reves; M F Newman; I Johnstone; C Winston; M M Brooks; A D Rosen; D B Mark; B Pitt; W Rogers; T Ryan; R Wiens; J A Blumenthal
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

7.  Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.

Authors:  David J Cohen; Tara A Lavelle; Ben Van Hout; Haiyan Li; Yang Lei; Katherine Robertus; Duane Pinto; Elizabeth A Magnuson; Thomas F Mcgarry; Scott K Lucas; Phillip A Horwitz; Carl A Henry; Patrick W Serruys; Friedrich W Mohr; A Pieter Kappetein
Journal:  Catheter Cardiovasc Interv       Date:  2011-09-26       Impact factor: 2.692

8.  Neuropsychological outcome after percutaneous coronary intervention or coronary artery bypass grafting: results from the Stent or Surgery (SoS) Trial.

Authors:  Peter Währborg; Jean E Booth; Tim Clayton; Fiona Nugara; John Pepper; William S Weintraub; Ulrich Sigwart; Rod H Stables
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

9.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.

Authors:  Patrick W Serruys; Marie-Claude Morice; A Pieter Kappetein; Antonio Colombo; David R Holmes; Michael J Mack; Elisabeth Ståhle; Ted E Feldman; Marcel van den Brand; Eric J Bass; Nic Van Dyck; Katrin Leadley; Keith D Dawkins; Friedrich W Mohr
Journal:  N Engl J Med       Date:  2009-02-18       Impact factor: 91.245

Review 10.  Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.

Authors:  Dena M Bravata; Allison L Gienger; Kathryn M McDonald; Vandana Sundaram; Marco V Perez; Robin Varghese; John R Kapoor; Reza Ardehali; Douglas K Owens; Mark A Hlatky
Journal:  Ann Intern Med       Date:  2007-10-15       Impact factor: 25.391
View more
  1 in total

1.  Diagnostic Policies Optimization for Chronic Diseases Based on POMDP Model.

Authors:  Wenqian Zhang; Haiyan Wang
Journal:  Healthcare (Basel)       Date:  2022-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.